Eric Faulkner
CIK: 0002113815
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNSP
CNS Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Faulkner Eric
Faulkner Eric (SEC CIK 0002113815) files insider reports with the SEC as Chief Technology Officer of CNS Pharmaceuticals, Inc. (CNSP).
Signal8 holds 2 ownership filings by Faulkner Eric (1 Form 3, 1 Form 4), filed on Mar 4, 2026. Those filings report 1 transaction, the latest on Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Faulkner Eric's filings is in HOUSTON, TX.
Recent filings by Faulkner Eric
- Mar 2, 2026: Grant or award of CNSP derivative securities (Form 4, code A).
Other insiders filing for CNS Pharmaceuticals, Inc. (CNSP)
- Fisher Michal, Director
- Levin Rami, CEO and President
- Charles Faith L., Director
- O'Loughlin Steve, Chief Financial Officer
- Keyes Jeffry R., Director
- Cockroft Bettina M., Director